Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis (Q83661349)
Jump to navigation
Jump to search
scientific article published on 18 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis |
scientific article published on 18 March 2011 |
Statements
Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis (English)
J Theodore Phillips
Gavin Giovannoni
Fred D Lublin
Paul W O'Connor
Chris H Polman
Ernie Willoughby
William Aschenbach
Amy Pace
Robert Hyde
Frederick E Munschauer
18 March 2011